Most read article(s)

You have access
C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways
Jeffrey S. Smith, Priya Alagesan, Nimit K. Desai, Thomas F. Pack, Jiao-Hui Wu, Asuka Inoue, Neil J. Freedman and Sudarshan Rajagopal

Molecular Pharmacology August 2017, 92 (2) 136-150; DOI: https://doi.org/10.1124/mol.117.108522
You have access
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill

Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65
You have access
Cyclopentenone Prostaglandins with Dienone Structure Promote Cross-Linking of the Chemoresistance-Inducing Enzyme Glutathione Transferase P1-1
Francisco J. Sánchez-Gómez, Beatriz Díez-Dacal, María A. Pajares, Oscar Llorca and Dolores Pérez-Sala

Molecular Pharmacology October 2010, 78 (4) 723-733; DOI: https://doi.org/10.1124/mol.110.065391
You have access
Cellular Mechanisms of Nociceptin/Orphanin FQ (N/OFQ) Peptide (NOP) Receptor Regulation and Heterologous Regulation by N/OFQ
Courtney L. Donica, Hibah O. Awwad, Deepak R. Thakker and Kelly M. Standifer

Molecular Pharmacology May 2013, 83 (5) 907-918; DOI: https://doi.org/10.1124/mol.112.084632
You have access
Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore
Hai M. Nguyen, Vikrant Singh, Brandon Pressly, David Paul Jenkins, Heike Wulff and Vladimir Yarov-Yarovoy

Molecular Pharmacology April 2017, 91 (4) 392-402; DOI: https://doi.org/10.1124/mol.116.108068
You have access
Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKKε and Reveal Mechanisms for Selective Inhibition
Tyler S. Beyett, Xinmin Gan, Shannon M. Reilly, Louise Chang, Andrew V. Gomez, Alan R. Saltiel, Hollis D. Showalter and John J. G. Tesmer

Molecular Pharmacology October 2018, 94 (4) 1210-1219; DOI: https://doi.org/10.1124/mol.118.112185
You have access
A Fibroblast Growth Factor 21–Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease
Sarah J. Woolsey, Melanie D. Beaton, Sara E. Mansell, Matilde Leon-Ponte, Janice Yu, Christopher L. Pin, Paul C. Adams, Richard B. Kim and Rommel G. Tirona

Molecular Pharmacology October 2016, 90 (4) 437-446; DOI: https://doi.org/10.1124/mol.116.104687
You have access
β-Arrestin-Dependent Actin Reorganization: Bringing the Right Players Together at the Leading Edge
Jungah Min and Kathryn DeFea

Molecular Pharmacology November 2011, 80 (5) 760-768; DOI: https://doi.org/10.1124/mol.111.072470
You have access
Current Knowledge and Perspectives on Histamine H₁ and H₂ Receptor Pharmacology: Functional Selectivity, Receptor Crosstalk, and Repositioning of Classic Histaminergic Ligands
Federico Monczor and Natalia Fernandez

Molecular Pharmacology November 2016, 90 (5) 640-648; DOI: https://doi.org/10.1124/mol.116.105981
You have access
Molecular Pharmacology of the Interaction of Anthracyclines with Iron
X. Xu, H. L. Persson and D. R. Richardson

Molecular Pharmacology August 2005, 68 (2) 261-271; DOI: https://doi.org/10.1124/mol.105.013383

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals